Timothy Brighton

5.3k total citations · 3 hit papers
58 papers, 3.4k citations indexed

About

Timothy Brighton is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Timothy Brighton has authored 58 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 25 papers in Internal Medicine and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Timothy Brighton's work include Venous Thromboembolism Diagnosis and Management (25 papers), Platelet Disorders and Treatments (22 papers) and Atrial Fibrillation Management and Outcomes (13 papers). Timothy Brighton is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (25 papers), Platelet Disorders and Treatments (22 papers) and Atrial Fibrillation Management and Outcomes (13 papers). Timothy Brighton collaborates with scholars based in Australia, Canada and United Kingdom. Timothy Brighton's co-authors include Cecilia Becattini, Pieter W. Kamphuisen, Rita Selby, Walter Ageno, Martin H. Prins, Bruce L. Davidson, Henri Bounameaux, Philip S. Wells, Bonno van Bellen and Rupert Bauersachs and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

Timothy Brighton

55 papers receiving 3.3k citations

Hit Papers

Cardiovascular Risk Factors and Venous Thromboembolism 2007 2026 2013 2019 2007 2017 2013 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiovascular Risk Factors and Venous Thromboembolism
    2007 728 citations Walter Ageno, Cecilia Becattini et al. Circulation profile →
  2. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
    2017 492 citations Anthonie W.A. Lensing, Martin H. Prins et al. New England Journal of Medicine profile →
  3. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
    2013 427 citations Martin H. Prins, Anthonie WA Lensing et al. Thrombosis Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Brighton Australia 23 2.2k 1.8k 1.1k 732 232 58 3.4k
Edelgard Lindhoff‐Last Germany 34 1.9k 0.9× 1.8k 1.0× 1.0k 1.0× 1.3k 1.8× 239 1.0× 148 3.7k
Alejandro Lazo‐Langner Canada 29 1.6k 0.7× 1.0k 0.6× 696 0.6× 588 0.8× 147 0.6× 169 3.2k
Susan R. Heckbert United States 22 2.0k 0.9× 1.4k 0.8× 1.0k 1.0× 681 0.9× 100 0.4× 30 3.5k
Rainer B. Zotz Germany 24 1.5k 0.7× 1.5k 0.8× 1.1k 1.0× 626 0.9× 48 0.2× 78 3.3k
Sigrid K. Brækkan Norway 36 2.9k 1.3× 1.9k 1.0× 1.1k 1.0× 738 1.0× 117 0.5× 167 4.6k
Patrick Mismetti France 33 2.9k 1.3× 2.2k 1.2× 628 0.6× 1.0k 1.4× 162 0.7× 154 4.2k
Sverre Christian Christiansen Norway 15 1.5k 0.7× 841 0.5× 982 0.9× 504 0.7× 126 0.5× 33 2.1k
Cesare Manotti Italy 19 1.4k 0.6× 1.7k 0.9× 626 0.6× 471 0.6× 341 1.5× 60 2.7k
Juan Carlos Souto Spain 31 1.3k 0.6× 1.0k 0.6× 1.9k 1.8× 487 0.7× 235 1.0× 145 3.7k
Gerd Lärfars Sweden 19 1.8k 0.8× 1.2k 0.6× 872 0.8× 720 1.0× 57 0.2× 46 2.5k

Countries citing papers authored by Timothy Brighton

Since Specialization
Citations

This map shows the geographic impact of Timothy Brighton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Brighton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Brighton more than expected).

Fields of papers citing papers by Timothy Brighton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Brighton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Brighton. The network helps show where Timothy Brighton may publish in the future.

Co-authorship network of co-authors of Timothy Brighton

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Brighton. A scholar is included among the top collaborators of Timothy Brighton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Brighton. Timothy Brighton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapman, Kent, Soma Mohammed, Leonardo Pasalic, et al.. (2023). A multicenter evaluation of the Technoscreen ADAMTS13 activity semi‐quantitative screening test for thrombotic thrombocytopenic purpura diagnosis and exclusion. International Journal of Laboratory Hematology. 45(4). 562–570. 5 indexed citations
2.
Kershaw, Geoffrey, Timothy Brighton, Sanjeev Chunilal, et al.. (2023). Platelet-activating functional assay resolution in vaccine-induced immune thrombotic thrombocytopenia: differential alignment to PF4 ELISA platforms. Research and Practice in Thrombosis and Haemostasis. 7(3). 100128–100128. 3 indexed citations
3.
Liang, Hai, David Connor, Heather Campbell, et al.. (2022). A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Blood Advances. 6(11). 3494–3506. 18 indexed citations
4.
Chan, Melissa V., Paul C. Armstrong, Marilena Crescente, et al.. (2022). A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia. Pathology. 54(6). 746–754. 4 indexed citations
5.
Favaloro, Emmanuel J., et al.. (2021). Effect of sample heat inactivation on test levels of HIT-IgG(PF4-H) detected by the ACL AcuStar. Thrombosis Research. 200. 12–15.
6.
Favaloro, Emmanuel J., Soma Mohammed, Mayuko Kondo, et al.. (2020). A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia. Pathology. 53(2). 247–256. 21 indexed citations
7.
Rabbolini, David J., David Connor, Marie‐Christine Morel‐Kopp, et al.. (2020). An integrated approach to inherited platelet disorders: results from a research collaborative, the Sydney Platelet Group. Pathology. 52(2). 243–255. 15 indexed citations
8.
Rodger, Marc, Nicole Langlois, Saskia Middeldorp, et al.. (2018). Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism. Thrombosis Research. 163. 128–131. 5 indexed citations
9.
Khan, Faizan, Alvi Rahman, Marc Carrier, et al.. (2017). Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis. BMJ Open. 7(9). 16950–16950. 4 indexed citations
10.
11.
Bauersachs, Rupert, Jan Beyer‐Westendorf, Henri Bounameaux, et al.. (2015). Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Thrombosis and Haemostasis. 114(9). 645–650. 35 indexed citations
12.
Simes, John, Cecilia Becattini, Giancarlo Agnelli, et al.. (2014). Aspirin for the Prevention of Recurrent Venous Thromboembolism. Circulation. 130(13). 1062–1071. 186 indexed citations
13.
Prins, Martin H., Anthonie WA Lensing, Rupert Bauersachs, et al.. (2013). Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thrombosis Journal. 11(1). 21–21. 427 indexed citations breakdown →
14.
Brighton, Timothy, John W. Eikelboom, K. Mann, et al.. (2012). Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism. New England Journal of Medicine. 367(21). 1979–1987. 386 indexed citations
15.
Brighton, Timothy, Simon McRae, Ross Baker, et al.. (2012). Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT. Thrombosis and Haemostasis. 107(3). 575–583. 31 indexed citations
16.
Brighton, Timothy, Simon McRae, Peter Mollee, et al.. (2011). Rapid diagnosis of heparin-induced thrombocytopenia (HIT) by whole blood impedance aggregometry: results of the Australian multi centre study. Queensland's institutional digital repository (The University of Queensland). 9. 82–82. 1 indexed citations
17.
18.
Wong, River Chun‐Wai, Emmanuel J. Favaloro, Stephen Adelstein, et al.. (2007). Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. Pathology. 40(1). 58–63. 31 indexed citations
19.
Manoharan, A., et al.. (2002). Platelet Dysfunction in Myelodysplastic Syndromes: A Clinicopathological Study. International Journal of Hematology. 76(3). 272–278. 31 indexed citations
20.
Brighton, Timothy & C.N. Chesterman. (2000). The clinical significance of antiphospholipid antibodies in patients without autoimmune disease. Australian and New Zealand Journal of Medicine. 30(6). 693–703.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edelgard Lindhoff‐Last Breakdown of academic impact, for papers by Alejandro Lazo‐Langner Breakdown of academic impact, for papers by Susan R. Heckbert Breakdown of academic impact, for papers by Rainer B. Zotz Breakdown of academic impact, for papers by Sigrid K. Brækkan Breakdown of academic impact, for papers by Patrick Mismetti Breakdown of academic impact, for papers by Sverre Christian Christiansen Breakdown of academic impact, for papers by Cesare Manotti Breakdown of academic impact, for papers by Juan Carlos Souto Breakdown of academic impact, for papers by Gerd Lärfars
Rankless by CCL
2026